KCNJ11 Antibody (N-term) Blocking Peptide

Artikelnummer: ABT-BP9209A
Artikelname: KCNJ11 Antibody (N-term) Blocking Peptide
Artikelnummer: ABT-BP9209A
Hersteller Artikelnummer: BP9209a
Alternativnummer: ABT-BP9209A-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: ATP-sensitive inward rectifier potassium channel 11, IKATP, Inward rectifier K(+) channel Kir62, Potassium channel, inwardly rectifying subfamily J member 11, KCNJ11
ATP-sensitive potassium (K(ATP)) channels are found in endocrine cells, neurons and both smooth and striated muscle, where they play an important role in controlling insulin secretion and vascular tone, and protect neurons under metabolic stress. Kir6.2 is a member of the inward rectifier potassium channel family, which is characterised by a greater tendency to allow potassium flow into the cell rather than out of it. It associates with the sulphonylurea receptor SUR1/ABCC8 to form a subfamily of K(ATP) channels that, when mutated or misregulated, are associated with forms of hyperinsulinemic hypoglycemia, neonatal diabetes, or pre-disposition to type 2 diabetes mellitus.
NCBI: 3767
UniProt: Q14654
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP9209a was selected from the N-term region of human KCNJ11. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.